Article | July 6, 2021

Outsourcing Drivers For Small Molecule Manufacturing

Source: ISR Reports

ISR’s recent survey of small molecule outsourcers found that the majority of respondents outsource for one of two reasons: for all of their manufacturing needs, or to augment their internal manufacturing capacity. However, API outsourcers are more likely to outsource for all of their needs, while drug product outsourcers conversely are more likely to outsource to increase internal capacity. Market access and emergency situations seem to be infrequent drivers for outsourcing across all small molecule manufacturing.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online